Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1253

1.

Synthesis and Evaluation of Fuligocandin B Derivatives with Activity for Overcoming TRAIL Resistance.

Arai MA, Masuda A, Suganami A, Tamura Y, Ishibashi M.

Chem Pharm Bull (Tokyo). 2018;66(8):810-817. doi: 10.1248/cpb.c18-00308.

2.

Outcome of direct oral anticoagulant treatment for acute lower limb deep venous thrombosis after total knee arthroplasty or total hip arthroplasty.

Mochizuki T, Ikari K, Yano K, Hiroshima R, Ishibashi M, Okazaki K.

Mod Rheumatol. 2018 Jul 25:1-15. doi: 10.1080/14397595.2018.1504396. [Epub ahead of print]

PMID:
30041559
3.

Prior vaccinations improve immunogenicity of inactivated influenza vaccine in young children aged 6 months to 3 years: A cohort study.

Ito K, Mugitani A, Irie S, Ishibashi M, Takasaki Y, Shindo S, Yokoyama T, Yamashita Y, Shibao K, Koyanagi H, Fukushima W, Ohfuji S, Maeda A, Kase T, Hirota Y.

Medicine (Baltimore). 2018 Jul;97(29):e11551. doi: 10.1097/MD.0000000000011551.

4.

Crystal structure of (-)-(R,E)-3-(1,3-benzodioxol-5-yl)-5-[(4S,5R)-5-hy-droxy-methyl-2,2-dimethyl-1,3-dioxolan-4-yl]-N,N-di-methyl-pent-4-enamide.

Oishi T, Ishii K, Ishibashi M, Sato T, Chida N.

Acta Crystallogr E Crystallogr Commun. 2018 May 18;74(Pt 6):825-828. doi: 10.1107/S2056989018007132. eCollection 2018 Jun 1.

5.

Development and characterization of a new rice cultivar, 'Chikushi-kona 85', derived from a starch-branching enzyme IIb-deficient mutant line.

Wada T, Yamaguchi O, Miyazaki M, Miyahara K, Ishibashi M, Aihara T, Shibuta T, Inoue T, Tsubone M, Toyosawa Y, Satoh H, Akaishi R, Yoshii Y, Ohtsubo K.

Breed Sci. 2018 Mar;68(2):278-283. doi: 10.1270/jsbbs.17069. Epub 2018 Apr 12.

6.

LPCAT3 deficiency in hematopoietic cells alters cholesterol and phospholipid homeostasis and promotes atherosclerosis.

Thomas C, Jalil A, Magnani C, Ishibashi M, Queré R, Bourgeois T, Bergas V, Ménégaut L, Patoli D, Le Guern N, Labbé J, Gautier T, de Barros JPP, Lagrost L, Masson D.

Atherosclerosis. 2018 May 18. pii: S0021-9150(18)30266-1. doi: 10.1016/j.atherosclerosis.2018.05.023. [Epub ahead of print]

PMID:
29866392
7.

Efficient production of Trastuzumab Fab antibody fragments in Brevibacillus choshinensis expression system.

Mizukami M, Onishi H, Hanagata H, Miyauchi A, Ito Y, Tokunaga H, Ishibashi M, Arakawa T, Tokunaga M.

Protein Expr Purif. 2018 Oct;150:109-118. doi: 10.1016/j.pep.2018.05.013. Epub 2018 May 29.

PMID:
29857036
8.

Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in Japan.

Kitajima K, Nakatani K, Yamaguchi K, Nakajo M, Tani A, Ishibashi M, Hosoya K, Morita T, Kinoshita T, Kaida H, Miyoshi Y.

Eur J Nucl Med Mol Imaging. 2018 May 12. doi: 10.1007/s00259-018-4008-1. [Epub ahead of print]

PMID:
29754160
9.

Collagen type I induces EGFR-TKI resistance in EGFR-mutated cancer cells by mTOR activation through Akt-independent pathway.

Yamazaki S, Higuchi Y, Ishibashi M, Hashimoto H, Yasunaga M, Matsumura Y, Tsuchihara K, Tsuboi M, Goto K, Ochiai A, Ishii G.

Cancer Sci. 2018 Jun;109(6):2063-2073. doi: 10.1111/cas.13624.

10.

Greetings from the chief editor.

Ishibashi M.

J Nat Med. 2018 Jun;72(3):595. doi: 10.1007/s11418-018-1216-8. No abstract available.

PMID:
29700701
11.

The Notch Inhibitors Isolated from Nerium indicum.

Arai MA, Akamine R, Hayashi N, Koyano T, Kowithayakorn T, Ishibashi M.

J Nat Prod. 2018 May 25;81(5):1235-1240. doi: 10.1021/acs.jnatprod.7b01031. Epub 2018 Apr 25.

PMID:
29693393
12.

The Notch inhibitor cowanin accelerates nicastrin degradation.

Arai MA, Akamine R, Tsuchiya A, Yoneyama T, Koyano T, Kowithayakorn T, Ishibashi M.

Sci Rep. 2018 Mar 29;8(1):5376. doi: 10.1038/s41598-018-23698-4.

13.

Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancer.

Kaida H, Azuma K, Toh U, Kawahara A, Sadashima E, Hattori S, Akiba J, Tahara N, Rominger A, Ishii K, Murakami T, Ishibashi M.

Hell J Nucl Med. 2018 Jan-Apr;21(1):35-42. doi: 10.1967/s002449910705. Epub 2018 Mar 20.

14.

Tumoricidal effect and pain relief after concurrent therapy by strontium-89 chloride and zoledronic acid for bone metastases.

Baba K, Kaida H, Hattori C, Muraki K, Kugiyama T, Fujita H, Ishibashi M.

Hell J Nucl Med. 2018 Jan-Apr;21(1):15-23. doi: 10.1967/s002449910702. Epub 2018 Mar 20.

15.

Total syntheses of schizandriside, saracoside and (±)-isolariciresinol with antioxidant activities.

Sampei M, Arai MA, Ishibashi M.

J Nat Med. 2018 Jun;72(3):651-654. doi: 10.1007/s11418-018-1198-6. Epub 2018 Mar 5.

PMID:
29508253
16.

[A Questionnaire Survey on Cooperation between Community Pharmacies and Hospitals in Outpatient Chemotherapy-Comparison of Roles of Pharmacists in Community Pharmacy and Hospitals].

Ishibashi M, Ishii M, Nagano M, Kiuchi Y, Iwamoto S.

Yakugaku Zasshi. 2018;138(3):425-435. doi: 10.1248/yakushi.17-00182. Japanese.

17.

Effects of white matter lesions on brain perfusion in patients with mild cognitive impairment.

Ishibashi M, Kimura N, Aso Y, Matsubara E.

Clin Neurol Neurosurg. 2018 May;168:7-11. doi: 10.1016/j.clineuro.2018.02.030. Epub 2018 Feb 24.

PMID:
29499394
18.

Two new coumarins and a new xanthone from the leaves of Rhizophora mucronata.

Taniguchi K, Funasaki M, Kishida A, Sadhu SK, Ahmed F, Ishibashi M, Ohsaki A.

Bioorg Med Chem Lett. 2018 Apr 1;28(6):1063-1066. doi: 10.1016/j.bmcl.2018.02.022. Epub 2018 Feb 12.

PMID:
29475587
19.

Novel cooperative pathway of c-Myc and Furin, a pro-protein convertase, in cell proliferation as a therapeutic target in ovarian cancers.

Hasegawa-Minato J, Toyoshima M, Ishibashi M, Zhang X, Shigeta S, Grandori C, Kitatani K, Yaegashi N.

Oncotarget. 2017 Dec 15;9(3):3483-3496. doi: 10.18632/oncotarget.23322. eCollection 2018 Jan 9.

20.

Intra- and inter-observer agreement in the visual interpretation of interim 18F-FDG PET/CT in malignant lymphoma: influence of clinical information.

Arimoto MK, Nakamoto Y, Higashi T, Ishimori T, Ishibashi M, Togashi K.

Acta Radiol. 2018 Jan 1:284185117751279. doi: 10.1177/0284185117751279. [Epub ahead of print]

PMID:
29333861
21.

Expression and characterization of the Renilla luciferase with the cumulative mutation.

Ishibashi M, Kawanabe R, Amaba N, Arai S, Laksmi FA, Komori K, Tokunaga M.

Protein Expr Purif. 2018 May;145:39-44. doi: 10.1016/j.pep.2017.12.010. Epub 2017 Dec 28.

PMID:
29288731
22.

Histological Chorioamnionitis as a Risk Factor for Preterm Birth without Disturbing Fetal Heart Rate: A Case-Control Study.

Kyozuka H, Yasuda S, Hiraiwa T, Ishibashi M, Kato K, Fujimori K.

Tohoku J Exp Med. 2017 Dec;243(4):289-295. doi: 10.1620/tjem.243.289.

23.

Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.

Ishibashi M, Yamaguchi H, Hirotani Y, Sakurada A, Endo T, Sugitani M, Takayama T, Makishima M, Esumi M.

Arch Virol. 2018 Apr;163(4):855-865. doi: 10.1007/s00705-017-3675-8. Epub 2017 Dec 16.

PMID:
29248968
24.

Syphilis of the pharynx.

Ishibashi M.

Int J Dermatol. 2018 Feb;57(2):240-241. doi: 10.1111/ijd.13869. Epub 2017 Dec 12. No abstract available.

PMID:
29231240
25.

Dehydropropylpantothenamide isolated by a co-culture of Nocardia tenerifensis IFM 10554T in the presence of animal cells.

Hara Y, Arai MA, Sakai K, Ishikawa N, Gonoi T, Yaguchi T, Ishibashi M.

J Nat Med. 2018 Jan;72(1):280-289. doi: 10.1007/s11418-017-1161-y. Epub 2017 Dec 5.

PMID:
29209902
26.

Sucupiranins A-L, Furanocassane Diterpenoids from the Seeds of Bowdichia virgilioides.

Endo Y, Kasahara T, Harada K, Kubo M, Etoh T, Ishibashi M, Ishiyama A, Iwatsuki M, Otoguro K, O Mura S, Akisue G, Hirano T, Kagechika H, Fukuyama Y, Ohsaki A.

J Nat Prod. 2017 Dec 22;80(12):3120-3127. doi: 10.1021/acs.jnatprod.7b00249. Epub 2017 Nov 28.

PMID:
29182338
27.

Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes.

Asayama T, Tamura H, Ishibashi M, Kuribayashi-Hamada Y, Onodera-Kondo A, Okuyama N, Yamada A, Shimizu M, Moriya K, Takahashi H, Inokuchi K.

Oncotarget. 2017 Oct 4;8(51):88904-88917. doi: 10.18632/oncotarget.21492. eCollection 2017 Oct 24.

28.

Analysis of major paralogs encoding the Fra a 1 allergen based on their organ-specificity in Fragaria × ananassa.

Ishibashi M, Nabe T, Nitta Y, Tsuruta H, Iduhara M, Uno Y.

Plant Cell Rep. 2018 Mar;37(3):411-424. doi: 10.1007/s00299-017-2237-6. Epub 2017 Nov 25.

PMID:
29177844
29.

Detection and validation of QTLs for milky-white grains caused by high temperature during the ripening period in Japonica rice.

Miyahara K, Wada T, Sonoda JY, Tsukaguchi T, Miyazaki M, Tsubone M, Yamaguchi O, Ishibashi M, Iwasawa N, Umemoto T, Kondo M.

Breed Sci. 2017 Sep;67(4):333-339. doi: 10.1270/jsbbs.16203. Epub 2017 Jul 28.

30.

Oxygen-15 labeled CO2, O2, and CO PET in small animals: evaluation using a 3D-mode microPET scanner and impact of reconstruction algorithms.

Horitsugi G, Watabe T, Kanai Y, Ikeda H, Kato H, Naka S, Ishibashi M, Matsunaga K, Isohashi K, Shimosegawa E, Hatazawa J.

EJNMMI Res. 2017 Oct 27;7(1):91. doi: 10.1186/s13550-017-0335-7.

31.

Ceramide Nanoliposomes as a MLKL-Dependent, Necroptosis-Inducing, Chemotherapeutic Reagent in Ovarian Cancer.

Zhang X, Kitatani K, Toyoshima M, Ishibashi M, Usui T, Minato J, Egiz M, Shigeta S, Fox T, Deering T, Kester M, Yaegashi N.

Mol Cancer Ther. 2018 Jan;17(1):50-59. doi: 10.1158/1535-7163.MCT-17-0173. Epub 2017 Oct 27.

PMID:
29079707
32.

[A amyotrophic lateral sclerosis (ALS) 4 family misdiagnosed as hereditary spastic paraplegia-a case report].

Taniguchi T, Hokezu Y, Okada T, Ishibashi M, Hashiguchi A, Matsuura E, Takashima H.

Rinsho Shinkeigaku. 2017 Nov 25;57(11):685-690. doi: 10.5692/clinicalneurol.cn-000996. Epub 2017 Oct 26. Japanese.

PMID:
29070749
33.

HDlive Flow silhouette mode for the diagnosis of uterine enhanced myometrial vascularity/arteriovenous malformations.

Tenkumo C, Kanenishi K, AboEllail MAM, Yamamoto K, Ishibashi M, Mori N, Tanaka H, Hata T.

J Med Ultrason (2001). 2018 Apr;45(2):349-352. doi: 10.1007/s10396-017-0823-4. Epub 2017 Aug 24.

PMID:
28840423
34.

Assessment of Mediastinal Tumors Using SUVmax and Volumetric Parameters on FDG-PET/CT.

Morita T, Tatsumi M, Ishibashi M, Isohashi K, Kato H, Honda O, Shimosegawa E, Tomiyama N, Hatazawa J.

Asia Ocean J Nucl Med Biol. 2017 Winter;5(1):22-29. doi: 10.22038/aojnmb.2016.7996.

35.

The efficacy of abatacept focusing on anti-CCP antibody in Japanese patients with rheumatoid arthritis for 104 weeks.

Mochizuki T, Yano K, Ikari K, Hiroshima R, Kawakami K, Koenuma N, Ishibashi M, Momohara S.

Mod Rheumatol. 2018 May;28(3):575-577. doi: 10.1080/14397595.2017.1365805. Epub 2017 Aug 24. No abstract available.

PMID:
28837415
36.

Notch Inhibitors from Calotropis gigantea That Induce Neuronal Differentiation of Neural Stem Cells.

Yoneyama T, Arai MA, Akamine R, Koryudzu K, Tsuchiya A, Sadhu SK, Ahmed F, Itoh M, Okamoto R, Ishibashi M.

J Nat Prod. 2017 Sep 22;80(9):2453-2461. doi: 10.1021/acs.jnatprod.7b00282. Epub 2017 Aug 17.

PMID:
28817274
37.

A retrospective study on the risk factors for bleeding events in warfarin therapy, focusing on renal function.

Hirai T, Hamada Y, Geka Y, Kuwana S, Hirai K, Ishibashi M, Fukaya Y, Kimura T.

Eur J Clin Pharmacol. 2017 Nov;73(11):1491-1497. doi: 10.1007/s00228-017-2316-1. Epub 2017 Aug 9.

PMID:
28795244
38.

Efficient Synthesis of Heterocyclic Flavonoids with Hedgehog Signal Inhibitory Activity.

Arai MA, Utsumi T, Yanase N, Fujimatsu T, Ishibashi M.

Chem Pharm Bull (Tokyo). 2017;65(8):784-795. doi: 10.1248/cpb.c17-00305.

39.

Evaluation of Parkinson's disease by neuromelanin-sensitive magnetic resonance imaging and 123I-FP-CIT SPECT.

Kuya K, Ogawa T, Shinohara Y, Ishibashi M, Fujii S, Mukuda N, Tanabe Y.

Acta Radiol. 2018 May;59(5):593-598. doi: 10.1177/0284185117722812. Epub 2017 Jul 25.

PMID:
28743197
40.

Flexible magnifying endoscopy with narrow band imaging for the diagnosis of uterine cervical tumors: A cooperative study among gastrointestinal endoscopists and gynecologists to explore a novel microvascular classification system.

Nishiyama N, Kanenishi K, Mori H, Kobara H, Fujihara S, Chiyo T, Kobayashi N, Matsunaga T, Ayaki M, Yachida T, Fujimori A, Oryu M, Tenkumo C, Ishibashi M, Hanaoka U, Hata T, Miyai Y, Kadota K, Haba R, Masaki T.

Oncol Lett. 2017 Jul;14(1):355-362. doi: 10.3892/ol.2017.6157. Epub 2017 May 11.

41.

Effects of denosumab treatment on bone mineral density and joint destruction in patients with rheumatoid arthritis.

Mochizuki T, Yano K, Ikari K, Kawakami K, Hiroshima R, Koenuma N, Ishibashi M, Momohara S.

J Bone Miner Metab. 2018 Jul;36(4):431-438. doi: 10.1007/s00774-017-0848-1. Epub 2017 Jul 5.

PMID:
28681148
42.

Identification of BMI1 Promoter Inhibitors from Beaumontia murtonii and Eugenia operculata.

Kaneta Y, Arai MA, Ishikawa N, Toume K, Koyano T, Kowithayakorn T, Chiba T, Iwama A, Ishibashi M.

J Nat Prod. 2017 Jun 23;80(6):1853-1859. doi: 10.1021/acs.jnatprod.7b00138. Epub 2017 Jun 9.

PMID:
28598616
43.

Immunogenicity study to investigate the interchangeability among three different types of polio vaccine: A cohort study in Japan.

Ohfuji S, Ito K, Ishibashi M, Shindo S, Takasaki Y, Yokoyama T, Yokoyama T, Yamashita Y, Shibao K, Nakano T, Tsuru T, Irie S, Hirota Y.

Medicine (Baltimore). 2017 Jun;96(23):e7073. doi: 10.1097/MD.0000000000007073.

44.

Understanding Why Children Commit Scale Errors: Scale Error and Its Relation to Action Planning and Inhibitory Control, and the Concept of Size.

Ishibashi M, Moriguchi Y.

Front Psychol. 2017 May 23;8:826. doi: 10.3389/fpsyg.2017.00826. eCollection 2017.

45.

Pictorial review of 18F-FDG PET/CT findings in musculoskeletal lesions.

Ishibashi M, Tanabe Y, Fujii S, Ogawa T.

Ann Nucl Med. 2017 Jul;31(6):437-453. doi: 10.1007/s12149-017-1182-3. Epub 2017 Jun 5.

PMID:
28585058
46.

Expression Profiling of Strawberry Allergen Fra a during Fruit Ripening Controlled by Exogenous Auxin.

Ishibashi M, Yoshikawa H, Uno Y.

Int J Mol Sci. 2017 Jun 2;18(6). pii: E1186. doi: 10.3390/ijms18061186.

47.

Total synthesis of agalloside, isolated from Aquilaria agallocha, by the 5-O-glycosylation of flavan.

Arai MA, Yamaguchi Y, Ishibashi M.

Org Biomol Chem. 2017 Jun 14;15(23):5025-5032. doi: 10.1039/c7ob01004d.

PMID:
28569322
48.

CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.

Ishibashi M, Neri S, Hashimoto H, Miyashita T, Yoshida T, Nakamura Y, Udagawa H, Kirita K, Matsumoto S, Umemura S, Yoh K, Niho S, Tsuboi M, Masutomi K, Goto K, Ochiai A, Ishii G.

Sci Rep. 2017 Apr 21;7:46662. doi: 10.1038/srep46662.

49.

Sharkquinone, a new ana-quinonoid tetracene derivative from marine-derived Streptomyces sp. EGY1 with TRAIL resistance-overcoming activity.

Abdelfattah MS, Elmallah MIY, Mohamed AA, Ishibashi M.

J Nat Med. 2017 Jul;71(3):564-569. doi: 10.1007/s11418-017-1086-5. Epub 2017 Apr 4.

PMID:
28378198
50.

Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.

Neri S, Miyashita T, Hashimoto H, Suda Y, Ishibashi M, Kii H, Watanabe H, Kuwata T, Tsuboi M, Goto K, Menju T, Sonobe M, Date H, Ochiai A, Ishii G.

Cancer Lett. 2017 Jun 1;395:20-30. doi: 10.1016/j.canlet.2017.02.026. Epub 2017 Mar 9.

PMID:
28286261

Supplemental Content

Loading ...
Support Center